There’s a calendar entry on most senior executives’ yearly schedule called “physical.” It blocks ninety minutes. It actually takes twenty. The output is a single sheet of paper with cholesterol, blood pressure, and maybe a glucose reading, plus a reassuring word from the doctor that everything looks normal. That was the standard of executive care for a long time. It isn’t anymore.
What the standard physical misses is most of what matters. A cholesterol panel can come back normal for years while arterial plaque builds in the background. Blood pressure measured at 8 a.m. in a quiet exam room, after coffee, tells you almost nothing about how the cardiovascular system holds up under the real stress of running a company. And the truth most senior leaders already suspect, after forty, is that the ceiling on their performance is mostly biological, not motivational.
Preventive medicine has caught up.
What’s Replacing the Standard Checkup
What’s emerged is essentially a diagnostic intake, several rungs above a routine checkup. It runs across four areas the standard physical either skims or skips: imaging, cardiovascular capacity, body composition done with real precision, and a biomarker panel that reaches well below the standard lipid screen.
The imaging part does most of the early-detection work. A full-body MRI can find solid tumors, aneurysms, and structural problems years before symptoms appear. DEXA scans pin down bone density and body fat with a precision that scales and BMI math can’t touch. Then there’s the capacity side. A VO2 max test, the one where you wear a mask on a treadmill or bike while the technician slowly cranks up the resistance, measures how much oxygen your body actually uses when pushed to maximum. The biomarker panel does the longest-horizon work, going past the basic lipid screen to look at insulin sensitivity, inflammation markers, ApoB, and the indicators that actually track how your system is aging.
The picture these build together is one of durability, not just absence of disease.
Why It Caught On With Founders First
The early adopters here were founders, not athletes or biohackers. The reason is mostly structural. Founders are trained to watch leading indicators. If you run a company, you don’t wait for revenue to crash before checking the dashboard. You watch the metrics that predict revenue, and you intervene when something looks off. Preventive diagnostics work the same way for the body.
VO2 max is the cleanest example. A JAMA Network Open study of more than 120,000 adults found that cardiorespiratory fitness was inversely associated with long-term mortality, with no observed upper limit of benefit. The lowest-fit group in that study carried a mortality risk higher than what’s associated with smoking, diabetes, or coronary artery disease. Pause on that for a second. A number on a treadmill test predicted death more reliably than three of the diseases doctors spend the most time treating. VO2 max stopped being a hobbyist score the moment that paper landed.
Cancer screening tells a similar story. The Harvard T.H. Chan School of Public Health notes that screening can catch tumors early, when they are easier to treat than after they’ve had years to grow. The caveat worth holding onto is that whole-body imaging in asymptomatic patients is genuinely debated inside the medical community. False positives can lead to follow-up procedures with their own risks. For most executives the tradeoff still tilts toward earlier knowledge, but it isn’t a free lunch.
For an executive, the framing is familiar. Find the problem early, when it’s still cheap to fix.
Stress, Sleep, and the Performance Tax
There’s a second driver behind this whole shift. The driver is performance, not mortality.
For founders, the more immediate worry is cognitive. They’re afraid of losing their edge before they’re done building the thing. Cognitive sharpness, energy, decision quality, and tolerance for stress all depend on the same physiological systems these tests evaluate. A high resting cortisol or an undiagnosed metabolic issue cuts both ways: it shortens the lifespan, and it dulls every workday between now and the end of it.
The connection to burnout is direct. Most stress management advice aimed at entrepreneurs focuses on schedules and habits, and rightly so, but it assumes the underlying machinery is fine. Preventive diagnostics test the machinery. When a CEO sees in actual data that their VO2 max has dropped 12 percent in two years, or that their inflammation markers have crept into the danger zone, the abstract idea of “taking care of yourself” suddenly has a number attached to it.
This is the same trend that pushed continuous glucose monitors and sleep trackers from niche products into mainstream wearables over the last five years. The audience for personal physiological data has expanded, and clinics have caught up.
A founder reading any decent guide on staying focused is essentially trying to optimize cognitive performance. Sleep quality, glucose stability, and cardiovascular fitness are the inputs that make sustained focus possible.
The New Clinics Built Around This Model
Traditional hospitals weren’t built for this kind of patient. Their workflows are designed for treating sickness, not for measuring slow-developing risk in a healthy 45-year-old who walked in feeling fine.
A handful of new clinics have built themselves around exactly that gap. Centers, like the ones from Biograph, bundle the whole stack into one or two days that an executive can actually fit into a calendar. Full-body MRI, DEXA, VO2 max, cardiovascular and metabolic screening, plus a consultation with a longevity-trained physician, in a single visit. The clinical model is closer to private banking than to a hospital outpatient department, which is part of the point. Most busy founders never got a thorough workup before because the friction was too high. That’s no longer a good excuse.
What It Means for the Bottom Line
The financial argument is hard to wave off. Replacing a CEO after a major health event carries costs that don’t sit cleanly on any balance sheet, particularly when the company is still founder-led and succession isn’t a worked-out process. Catching a serious illness at stage 3 instead of stage 1 is a personal disaster on its own, and inside a founder-driven business it ripples straight through the org chart.
Boards have started to notice. Some now reimburse or directly cover executive health memberships as part of leadership comp. The logic mirrors D&O insurance. The asset being protected is the operator.
The Takeaway
The annual physical isn’t going anywhere, and it shouldn’t. As a low-cost baseline for most adults, it remains a sensible starting point. The point is that it has stopped being the ceiling. The ceiling has moved up several notches, and the new picture you can build of your own physiology is detailed enough to give you a few years of warning before anything goes badly wrong.
For a generation of founders who built their companies on better data, that’s a hard offer to turn down.
